Ensemble Capital Talks with CNBC about Illumina & Nintendo
Late last week, Ensemble’s CIO Sean Stannard-Stockton appeared on CNBC to talk about our investment outlook and some of our holdings. In the clip below, Sean presents our thinking on Illumina and Nintendo.
- The acquisition of GRAIL has created a major regulatory headache for Illumina and caused investors to lose confidence in management. But with the CEO stepping down, it is clear that the GRAIL situation will be resolved one way or another as shareholder concerns have been recognized.
- Carl Icahn’s partially successful activism campaign is predicated on the idea that core Illumina is a much, much more valuable company that the stock market valuation currently reflects. While it may take more time to resolve the GRAIL situation than Icahn would like, it will be resolved at some point and we agree that core Illumina is worth much more than the current share price.
- It is important that investors not lose sight of the fact that Illumina’s genetic sequencing technology is one of the most important technologies that exists today. The technology was instrumental in the development of the COVID vaccine, the acquisition of GRAIL is based on Illumina’s critical role in radically reducing cancer deaths, and there is widespread agreement in the medical field that genetic sequencing is the key to the next decade of medical advancements.
- The massive box office success of Nintendo’s Super Mario movie demonstrates the widespread appeal of their intellectual property. A majority of movie goers were adults, not kids, showing the nostalgic power of Nintendo’s games, which today’s parents grew up playing in the 1980s.
Click on the image below to watch the full interview.
For more information about positions owned by Ensemble Capital on behalf of clients as well as additional disclosure information related to this post, please CLICK HERE.
While we do not accept public comments on this blog for compliance reasons, we encourage readers to contact us with their thoughts.
Past performance is no guarantee of future results. All investments in securities carry risks, including the risk of losing one’s entire investment. The opinions expressed within this blog post are as of the date of publication and are provided for informational purposes only. Content will not be updated after publication and should not be considered current after the publication date. All opinions are subject to change without notice and due to changes in the market or economic conditions may not necessarily come to pass. Nothing contained herein should be construed as a comprehensive statement of the matters discussed, considered investment, financial, legal, or tax advice, or a recommendation to buy or sell any securities, and no investment decision should be made based solely on any information provided herein. Links to third party content are included for convenience only, we do not endorse, sponsor, or recommend any of the third parties or their websites and do not guarantee the adequacy of information contained within their websites. Please follow the link above for additional disclosure information.